Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries.

CONCLUSION: Adjuvant and definitive PT are being used in the treatment of TMs. Early results of the largest such cohort reported to date demonstrates an acceptable rate of recurrence with a favorable toxicity profile. Longer follow-up and a larger patient cohort are needed to confirm these findings.
PMID: 30784340 [PubMed - as supplied by publisher]

Source: Acta Oncologica - February 20, 2019 Category: Cancer & Oncology Authors: Mercado CE, Hartsell WF, Simone CB, Tsai HK, Vargas CE, Zhu HJ, Henderson RH, Zeng J, Larson GL, Hoppe BS Tags: Acta Oncol Source Type: research